Cargando…
Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan
IMPORTANCE: Quality assurance of molecular tumor boards (MTBs) is crucial in cancer genome medicine. OBJECTIVE: To evaluate the concordance of recommendations by MTBs and centrally developed consensus treatment recommendations at all 12 leading institutions for cancer genomic medicine in Japan using...
Autores principales: | Naito, Yoichi, Sunami, Kuniko, Kage, Hidenori, Komine, Keigo, Amano, Toraji, Imai, Mitsuho, Koyama, Takafumi, Ennishi, Daisuke, Kanai, Masashi, Kenmotsu, Hirotsugu, Maeda, Takahiro, Morita, Sachi, Sakai, Daisuke, Watanabe, Kousuke, Shirota, Hidekazu, Kinoshita, Ichiro, Yoshioka, Masashiro, Mamesaya, Nobuaki, Ito, Mamoru, Kohsaka, Shinji, Saigusa, Yusuke, Yamamoto, Kouji, Hirata, Makoto, Tsuchihara, Katsuya, Yoshino, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855299/ https://www.ncbi.nlm.nih.gov/pubmed/36469316 http://dx.doi.org/10.1001/jamanetworkopen.2022.45081 |
Ejemplares similares
-
Chronological improvement in precision oncology implementation in Japan
por: Sunami, Kuniko, et al.
Publicado: (2022) -
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors
por: Imai, Mitsuho, et al.
Publicado: (2022) -
The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan
por: Sunami, Kuniko, et al.
Publicado: (2021) -
A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence
por: Sunami, Kuniko, et al.
Publicado: (2023) -
Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
por: Mamesaya, Nobuaki, et al.
Publicado: (2017)